{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:55:18Z","timestamp":1791237318147,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtm.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T11:35:50Z","timestamp":1616499350000},"page":"369-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["VEGFR-1\/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"21","author":[{"given":"Jennifer","family":"Bosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Gabri\u00ebls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-0842","authenticated-orcid":false,"given":"Mayank","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna M.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilish","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene","family":"Josiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuraman","family":"Meiyappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Traylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"De Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-9978","authenticated-orcid":false,"given":"Christophe","family":"Blanchetot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8707-0084","authenticated-orcid":false,"given":"Hans","family":"de Haard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7689-1493","authenticated-orcid":false,"given":"Heather S.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.03.013_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtm.2021.03.013_bib2","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.013_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0092-8674(95)90471-9","article-title":"Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy","volume":"82","author":"Brenman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.03.013_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fphys.2013.00381","article-title":"Functional muscle ischemia in Duchenne and Becker muscular dystrophy","volume":"4","author":"Thomas","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2021.03.013_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2044-5040-3-9","article-title":"Vascular-targeted therapies for Duchenne muscular dystrophy","volume":"3","author":"Ennen","year":"2013","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2021.03.013_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fphys.2014.00050","article-title":"Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells","volume":"5","author":"Shimizu-Motohashi","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2021.03.013_bib7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00018-019-03006-7","article-title":"Targeting angiogenesis in Duchenne muscular dystrophy","volume":"76","author":"Podkalicka","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtm.2021.03.013_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.omtm.2021.03.013_bib9","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1096\/fj.07-8459com","article-title":"VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice","volume":"21","author":"Messina","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2021.03.013_bib10","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/mt.2009.136","article-title":"Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle","volume":"17","author":"Deasy","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.03.013_bib11","first-page":"1825","article-title":"Adeno-associated virus serotype 9 mediated vascular endothelial growth factor gene overexpression in mdx mice","volume":"15","author":"Song","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.omtm.2021.03.013_bib12","doi-asserted-by":"crossref","first-page":"e0174315","DOI":"10.1371\/journal.pone.0174315","article-title":"ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice","volume":"12","author":"Gutpell","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.013_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yexcr.2005.10.017","article-title":"VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype","volume":"312","author":"Nagy","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omtm.2021.03.013_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10456-012-9304-y","article-title":"VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting","volume":"16","author":"Gianni-Barrera","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1016\/j.omtm.2021.03.013_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1067\/mcp.2002.126179","article-title":"A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans","volume":"72","author":"Eppler","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtm.2021.03.013_bib16","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.013_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BJ20101490","article-title":"Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing","volume":"436","author":"Ikeda","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtm.2021.03.013_bib18","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1172\/JCI76864","article-title":"Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications","volume":"124","author":"Fan","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.03.013_bib19","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1093\/hmg\/ddq334","article-title":"Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice","volume":"19","author":"Verma","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.03.013_bib20","doi-asserted-by":"crossref","first-page":"e1008468","DOI":"10.1371\/journal.pgen.1008468","article-title":"Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy","volume":"15","author":"Verma","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2021.03.013_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10974-015-9406-4","article-title":"What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?","volume":"36","author":"Manning","year":"2015","journal-title":"J.\u00a0Muscle Res. Cell Motil."},{"key":"10.1016\/j.omtm.2021.03.013_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/protein\/gzw003","article-title":"Combining somatic mutations present in different in\u00a0vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics","volume":"29","author":"Klarenbeek","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.omtm.2021.03.013_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.sbi.2016.10.019","article-title":"Camelid and shark single domain antibodies: structural features and therapeutic potential","volume":"45","author":"K\u00f6nning","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.omtm.2021.03.013_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.03.013_bib25","doi-asserted-by":"crossref","first-page":"284ra56","DOI":"10.1126\/scitranslmed.aaa1983","article-title":"Monoclonal antibodies against GARP\/TGF-\u03b21 complexes inhibit the immunosuppressive activity of human regulatory T\u00a0cells in\u00a0vivo","volume":"7","author":"Cuende","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.03.013_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.str.2016.12.012","article-title":"Structure of the full-length VEGFR-1 extracellular domain in complex with VEGF-A","volume":"25","author":"Markovic-Mueller","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.omtm.2021.03.013_bib27","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.4049\/jimmunol.164.10.5313","article-title":"The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc \u03b3 RI and Fc \u03b3 RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A","volume":"164","author":"Wines","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2021.03.013_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2021.03.013_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-018-00687-z","article-title":"Emerging strategies in the treatment of Duchenne muscular dystrophy","volume":"15","author":"Shieh","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtm.2021.03.013_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm9010001","article-title":"Restoring dystrophin expression in Duchenne muscular dystrophy: current status of therapeutic approaches","volume":"9","author":"Shimizu-Motohashi","year":"2019","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.omtm.2021.03.013_bib31","doi-asserted-by":"crossref","first-page":"13818","DOI":"10.1073\/pnas.250379497","article-title":"Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy","volume":"97","author":"Sander","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.013_bib32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","volume":"36","author":"Turanov","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2021.03.013_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/17460441.2018.1480607","article-title":"Strategies for improving the specificity of siRNAs for enhanced therapeutic potential","volume":"13","author":"Gatta","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.omtm.2021.03.013_bib34","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI65385","article-title":"Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer","volume":"123","author":"Chatterjee","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.03.013_bib35","doi-asserted-by":"crossref","first-page":"re21","DOI":"10.1126\/stke.2001.112.re21","article-title":"VEGF receptor signal transduction","volume":"2001","author":"Matsumoto","year":"2001","journal-title":"Sci. STKE"},{"key":"10.1016\/j.omtm.2021.03.013_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.omtm.2021.03.013_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.stem.2018.09.007","article-title":"Muscle satellite cell cross-talk with a vascular niche maintains quiescence via VEGF and notch signaling","volume":"23","author":"Verma","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2021.03.013_bib38","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1542\/peds.2008-1670","article-title":"Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia\/chronic lung disease","volume":"123","author":"Hasan","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2021.03.013_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.earlhumdev.2005.09.010","article-title":"Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates","volume":"82","author":"Boutsikou","year":"2006","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.omtm.2021.03.013_bib40","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1158\/0008-5472.CAN-05-4010","article-title":"Effect of target dynamics on pharmacokinetics of a novel therapeutic antibody against the epidermal growth factor receptor: implications for the mechanisms of action","volume":"66","author":"Lammerts van Bueren","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2021.03.013_bib41","doi-asserted-by":"crossref","first-page":"e27514","DOI":"10.1371\/journal.pone.0027514","article-title":"A two-compartment model of VEGF distribution in the mouse","volume":"6","author":"Yen","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.013_bib42","doi-asserted-by":"crossref","first-page":"e1005445","DOI":"10.1371\/journal.pcbi.1005445","article-title":"A computational analysis of in\u00a0vivo VEGFR activation by multiple co-expressed ligands","volume":"13","author":"Clegg","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.omtm.2021.03.013_bib43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/psp4.12224","article-title":"Pharmacokinetics of monoclonal antibodies","volume":"6","author":"Ryman","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.omtm.2021.03.013_bib44","doi-asserted-by":"crossref","first-page":"e0217061","DOI":"10.1371\/journal.pone.0217061","article-title":"Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates","volume":"14","author":"Walker","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.013_bib45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1369\/0022155415573324","article-title":"Human islets have fewer blood vessels than mouse islets and the density of islet vascular structures is increased in type 2 diabetes","volume":"63","author":"Brissova","year":"2015","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2021.03.013_bib46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00432-018-2809-z","article-title":"Melanoma tumour vasculature heterogeneity: from mice models to human","volume":"145","author":"Pautu","year":"2019","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.omtm.2021.03.013_bib47","doi-asserted-by":"crossref","first-page":"e44791","DOI":"10.1371\/journal.pone.0044791","article-title":"Expression of VEGF receptors on endothelial cells in mouse skeletal muscle","volume":"7","author":"Imoukhuede","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.013_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2474-7-23","article-title":"Transcriptome-scale similarities between mouse and human skeletal muscles with normal and myopathic phenotypes","volume":"7","author":"Kho","year":"2006","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.omtm.2021.03.013_bib49","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"key":"10.1016\/j.omtm.2021.03.013_bib50","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/hmg\/5.8.1149","article-title":"Differential expression of dystrophin isoforms in strains of mdx mice with different mutations","volume":"5","author":"Im","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.03.013_bib51","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.ajpath.2011.07.009","article-title":"mdx(5cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice","volume":"179","author":"Beastrom","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2021.03.013_bib52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature07414","article-title":"Sarcolemma-localized nNOS is required to maintain activity after mild exercise","volume":"456","author":"Kobayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.03.013_bib53","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0092-8674(93)90615-W","article-title":"Targeted disruption of the neuronal nitric oxide synthase gene","volume":"75","author":"Huang","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.03.013_bib54","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/hmg\/ddi197","article-title":"Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium","volume":"14","author":"Wehling-Henricks","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.03.013_bib55","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1371\/journal.pone.0000806","article-title":"Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy","volume":"2","author":"Asai","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.013_bib56","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.03.013_bib57","doi-asserted-by":"crossref","first-page":"P1.6-062","DOI":"10.1212\/WNL.92.15_supplement.P1.6-062","article-title":"A phase 1b\/2 study of the anti-myostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy: a 72-week treatment update","volume":"92","author":"Wagner","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2021.03.013_bib58","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.nmd.2019.06.455","article-title":"A phase 2 randomized placebo-control trial of domagrozumab in boys with Duchenne muscular dystrophy (DMD)","volume":"29","author":"Marraffino","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2021.03.013_bib59","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1164\/rccm.201707-1371OC","article-title":"Anti-sFlt-1 therapy preserves lung alveolar and vascular growth in antenatal models of bronchopulmonary dysplasia","volume":"197","author":"Wallace","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2021.03.013_bib60","first-page":"51303","article-title":"Assessing functional performance in the mdx mouse model","author":"Aartsma-Rus","year":"2014","journal-title":"J.\u00a0Vis. Exp."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012100053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012100053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:23Z","timestamp":1762421123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012100053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":60,"alternative-id":["S232905012100053X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.03.013","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEGFR-1\/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Shire Human Genetic Therapies.","name":"copyright","label":"Copyright"}]}}